High Tide Inc. announced on Jan. 13, 2025, its intention to enter into the German medical cannabis market by acquiring a 51% interest in Purecan GmbH for approximately €4.8 million.
During ongoing due diligence, the company reassessed the optimal structure for this transaction and is now exploring alternative arrangements with Purecan to allow High Tide to maintain its planned commercial exposure into the German market.
There is no certainty that an alternative arrangement with Purecan will proceed. High Tide will update the market as required. The company continues to be committed to the German medical cannabis market and will explore both alternative structures with Purecan and other opportunities for entry into Germany.
For more information:
High Tide
info@hightide.com
hightideinc.com